News
Anne Wojcicki stepped down as 23andMe's CEO as the company filed for bankruptcy protection. She cofounded the genetic testing company after a career on Wall Street. Here's a closer look at her ...
Hosted on MSN15d
Former YouTube CEO Susan Wojcicki's sisters remember her legacyYouTube sought to honor its former CEO Susan Wojcicki by sharing a blog post that she wrote in June, two months before she died from lung cancer at 56 years old. The blog post, shared on Monday ...
Hosted on MSN20d
Susan Wojcicki, former CEO of YouTube, dead at 56Susan Wojcicki, the former CEO of YouTube, died "after two years of living with cancer," Alphabet CEO Sunder Pichai wrote on X, adding that he was "unbelievably saddened by the loss." She was 56.
5d
MoneyWeek on MSNAnne Wojcicki: the 'daring' 23andMe CEO who reached too farAnne Wojcicki dreamed of a revolution in personal genomics and medicine. She set up 23andMe to realise her vision in 2006.
23andMe filed for Chapter 11 bankruptcy and CEO Anne Wojcicki has stepped down. The DNA testing company faced challenges including a failed privatization attempt and a data breach. 23andMe will ...
Her late sister Susan Wojcicki was Google's first marketing manager and went on to become CEO of YouTube before stepping down in 2023. Susan died from cancer the following year. 23andMe went ...
Wojcicki is the younger sister of late YouTube CEO Susan Wojcicki and the ex-wife of Google cofounder Sergey Brin. Wojcicki cofounded the company in 2006 and took 23andMe public in June 2021 through a ...
Her eldest sister, Susan Wojcicki, is the former CEO of YouTube and previously served as a senior vice president at Google. Their middle sister, Dr. Janet Wojcicki, is an anthropologist and ...
Her late sister Susan Wojcicki was Google's first marketing manager and went on to become CEO of YouTube before stepping down in 2023. Susan died from cancer the following year. 23andMe went public in ...
YouTube CEO Susan Wojcicki has laid out a plan to stop exploitative YouTube videos targeting children. Credit: Karol Serewis/Gallo Images Poland/Getty Images More people will be reviewing content ...
The patient advocacy startup is set to be valued at more than $300 million after the Series B round, Business Insider has learned.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results